Nitric oxide connecting device for treating pulmonary hypertension
By designing a NO connection device for treating pulmonary hypertension, real-time monitoring and control of NO concentration and nitrogen dioxide are achieved, solving the problem of lack of precise control and monitoring in the prior art, and significantly improving the safety and efficiency of treatment.
Patent Information
- Application Number
- CN202421677720.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Utility models(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-16
- Publication Date
- 2025-05-06
- Estimated Expiration
- 2034-07-16
AI Technical Summary
The existing NO gas supply devices lack precise concentration control and nitrogen dioxide monitoring when treating pulmonary hypertension, which can easily lead to toxic side effects and lung tissue damage.
A nitric oxide connection device is designed, including NO storage tank, pressure reducing valve, flowmeter, NO monitor and nitrogen dioxide monitor, through these components, real-time monitoring and control of NO concentration and nitrogen dioxide.
It significantly improves the standardized implementation of NO treatment, ensures the safety and efficiency of the treatment effect, reduces the toxic side effects caused by NO reaction, and protects the patient's lung tissue.
Smart Images

Figure CN222828912U_ABST
Abstract
Description
Technical Field
[0001] The utility model relates to the technical field of medical equipment, in particular to a nitric oxide connecting device for treating pulmonary hypertension. Background Art
[0002] Pulmonary hypertension is a life-threatening disease caused by a variety of reasons that lead to malignant increase in pulmonary vascular resistance, resulting in pulmonary vascular remodeling, and gradually develops into right heart failure and death. NO (nitric oxide) is an important endogenous bioactive molecule. NO dilates blood vessels by increasing cGMP (cyclic guanosine monophosphate) in vascular smooth muscle cells. In the disease state, endothelial cells cause changes in blood flow or blood pressure due to NO metabolic disorders.
[0003] The treatment of primary pulmonary hypertension by inhalation of exogenous NO has been successful, and it has been found that inhaled NO has a dose-dependent pulmonary vasodilation effect, which can reduce pulmonary vascular resistance and pulmonary artery pressure. This has triggered extensive international research on the use of inhaled NO for pulmonary hypertension-related diseases. Cylinder gas supply is common in clinical applications, and clinical connection and control are controlled by oxygen devices, lacking precise concentration calculations, and no monitoring of the generated nitrogen dioxide, which can easily cause toxic side effects and damage the patient's lung tissue. Utility Model Content
[0004] The purpose of the utility model is to provide a nitric oxide connection device for treating pulmonary hypertension, so as to solve the problems raised in the above background technology.
[0005] To achieve the above-mentioned purpose, the utility model provides the following technical solution: a nitric oxide connection device for treating pulmonary hypertension, comprising a NO storage tank, and also comprising:
[0006] A pressure reducing valve is arranged outside the NO storage tank, a connecting assembly is arranged outside the pressure reducing valve, and a transmission assembly for transmitting gas is arranged outside the connecting assembly;
[0007] A flow meter for monitoring gas flow is installed on the outside of the transmission component, a NO monitor for monitoring NO concentration is arranged on the outside of the flow meter, a connecting pipe is arranged on the outside of the NO monitor, a ventilator tube is arranged on the outside of the connecting pipe, a control valve is arranged on the outside of the ventilator tube, and a NO monitor is arranged on the outside of the control valve.
[0008] Preferably, the connection assembly includes a first fixed pipe and a second fixed pipe arranged outside the NO storage tank, the pressure reducing valve and the NO storage tank are connected through the first fixed pipe, and the second fixed pipe is arranged outside the pressure reducing valve.
[0009] Preferably, a mounting pipe is provided on the outer side of the NO monitor, and the control valve is mounted on the mounting pipe.
[0010] Preferably, the transmission component includes a connector arranged on the outside of the second fixed tube, and a catheter is installed on the outside of the connector.
[0011] Preferably, one end of the conduit away from the second fixed pipe is mounted on the flow meter.
[0012] Preferably, a vertical pipe is installed on the top of the flow meter, and the NO monitor is installed on the outside of the vertical pipe.
[0013] Preferably, the connecting tube is installed on the outside of the NO monitor, and the ventilator tube sleeve is arranged on the outside of the connecting tube.
[0014] Compared with the prior art, the beneficial effects of the utility model are as follows:
[0015] The utility model is connected to the patient through a gas control valve, a nitric oxide monitor, a nitrogen dioxide monitor and a connecting tube, and uses a NO monitor to display the NO concentration, thereby controlling the NO concentration within the treatment range, thereby significantly improving the standardized implementation of NO treatment, thereby ensuring the therapeutic efficacy, and using NO to treat PAH more safely and efficiently. The NO2 monitor can not only effectively monitor the reaction of NO and oxygen, but also observe NO2 in time to avoid damaging lung tissue and further reduce the toxic side effects caused by the NO reaction. BRIEF DESCRIPTION OF THE DRAWINGS
[0016] Figure 1 A schematic diagram of the structure of a nitric oxide connection device for treating pulmonary hypertension provided by the utility model;
[0017] Figure 2 A schematic diagram of the structure of the connection assembly provided by the utility model;
[0018] Figure 3 A schematic diagram of the structure of the flow meter and NO2 monitor provided by the utility model;
[0019] Figure 4 This is a schematic diagram of the NO monitor and control valve structure provided by the utility model.
[0020] In the figure: 1. NO storage tank; 2. pressure reducing valve; 3. NO monitor; 4. connecting assembly; 401. first fixed pipe; 402. second fixed pipe; 5. transmission assembly; 501. connector; 502. catheter; 6. control valve; 7. flow meter; 8. NO2 monitor; 9. connecting pipe; 10. ventilator pipe; 11. vertical pipe; 12. installation pipe. DETAILED DESCRIPTION
[0021] The following will be combined with the drawings in the embodiments of the utility model to clearly and completely describe the technical solutions in the embodiments of the utility model. Obviously, the described embodiments are only part of the embodiments of the utility model, not all of the embodiments. Based on the embodiments in the utility model, all other embodiments obtained by ordinary technicians in this field without creative work are within the scope of protection of the utility model.
[0022] See also Figure 1-4 As shown, a nitric oxide connection device for treating pulmonary hypertension includes a NO storage tank 1, and also includes: a pressure reducing valve 2 arranged outside the NO storage tank 1, the pressure reducing valve 2 is used to control the gas pressure, a connecting component 4 is arranged outside the pressure reducing valve 2, and a transmission component 5 for transmitting gas is arranged outside the connecting component 4. The pressure reducing valve 2 and the transmission component 5 are connected by the connecting component 4; a flow meter 7 for monitoring the gas flow rate is installed outside the transmission component 5, and the gas flow rate is detected by the flow meter 7. A NO2 monitor 8 for monitoring the NO2 concentration is arranged outside the flow meter 7, and the NO2 monitor 8 is used to monitor the NO2 concentration in the gas, and a connecting pipe 9 is arranged outside the NO2 monitor 8, and a ventilator tube 10 is arranged outside the connecting pipe 9. The device is connected to the ventilator and the patient's mouth by using the connecting pipe 9 and the ventilator tube 10, and a control valve 6 is arranged outside the ventilator tube 10, and a NO monitor 3 is arranged outside the control valve 6, and the NO monitor 3 is used to monitor the NO concentration.
[0023] The connecting assembly 4 includes a first fixed pipe 401 and a second fixed pipe 402 arranged outside the NO storage tank 1. The first fixed pipe 401 is installed on the NO storage tank 1. The pressure reducing valve 2 and the NO storage tank 1 are connected through the first fixed pipe 401. The second fixed pipe 402 is arranged outside the pressure reducing valve 2.
[0024] A mounting pipe 12 is provided outside the NO monitor 3, the mounting pipe 12 is welded to the NO monitor 3, the control valve 6 is mounted on the mounting pipe 12, and the control valve 6 is threadedly connected to the outside of the mounting pipe 12. The control valve 6 is used to control the gas output.
[0025] The transmission assembly 5 includes a connector 501 disposed outside the second fixed pipe 402, and a conduit 502 is installed outside the connector 501; and one end of the conduit 502 away from the second fixed pipe 402 is installed on the flow meter 7. The gas is transmitted to the flow meter 7 through the conduit 502.
[0026] A vertical pipe 11 is installed on the top of the flow meter 7, and the NO2 monitor 8 is installed on the outside of the vertical pipe 11; the connecting pipe 9 is installed on the outside of the NO2 monitor 8, and the NO2 monitor 8 is installed on the top of the flow meter 7 through the vertical pipe 11, and the ventilator tube 10 is sleeved on the outside of the connecting pipe 9.
[0027] Working principle: NO concentration is displayed by NO monitor 3, so as to control NO concentration within the treatment range, which can significantly improve the standardized implementation of NO treatment, thereby ensuring the therapeutic efficacy and using NO to treat PAH more safely and efficiently. NO2 monitor 8 can not only effectively monitor the reaction between NO and oxygen, but also observe NO2 in time to avoid damage to lung tissue and further reduce the toxic side effects caused by NO reaction.
[0028] It should be noted that, in this article, relational terms such as first and second, etc. are only used to distinguish one entity or operation from another entity or operation, and do not necessarily require or imply any such actual relationship or order between these entities or operations. Moreover, the terms "include", "comprise" or any other variants thereof are intended to cover non-exclusive inclusion, so that a process, method, article or device including a series of elements includes not only those elements, but also other elements not explicitly listed, or also includes elements inherent to such process, method, article or device. In the absence of further restrictions, the elements defined by the sentence "comprise a ..." do not exclude the presence of other identical elements in the process, method, article or device including the elements.
[0029] Although embodiments of the present invention have been shown and described, it will be appreciated by those skilled in the art that various changes, modifications, substitutions and variations may be made to the embodiments without departing from the principles and spirit of the present invention, and that the scope of the present invention is defined by the appended claims and their equivalents.
Claims
1. A nitric oxide connection device for treating pulmonary hypertension, comprising a NO storage tank (1), characterized in that: Also includes: A pressure reducing valve (2) is arranged outside the NO storage tank (1), a connecting assembly (4) is arranged outside the pressure reducing valve (2), and a transmission assembly (5) for transmitting gas is arranged outside the connecting assembly (4); A flow meter (7) for monitoring gas flow is installed on the outside of the transmission component (5), and a NO2 monitor (8) for monitoring NO2 concentration is arranged on the outside of the flow meter (7). A connecting pipe (9) is arranged on the outside of the NO2 monitor (8), and a ventilator tube (10) is arranged on the outside of the connecting pipe (9). A control valve (6) is arranged on the outside of the ventilator tube (10), and a NO monitor (3) is arranged on the outside of the control valve (6).
2. The nitric oxide connection device for treating pulmonary hypertension according to claim 1, characterized in that: The connection assembly (4) comprises a first fixed pipe (401) and a second fixed pipe (402) arranged outside the NO storage tank (1); the pressure reducing valve (2) and the NO storage tank (1) are connected via the first fixed pipe (401); and the second fixed pipe (402) is arranged outside the pressure reducing valve (2).
3. The nitric oxide connection device for treating pulmonary hypertension according to claim 1, characterized in that: A mounting pipe (12) is provided on the outside of the NO monitor (3), and the control valve (6) is mounted on the mounting pipe (12).
4. The nitric oxide connection device for treating pulmonary hypertension according to claim 2, characterized in that: The transmission component (5) comprises a connector (501) arranged outside the second fixed tube (402), and a guide tube (502) is installed outside the connector (501).
5. The nitric oxide connection device for treating pulmonary hypertension according to claim 4, characterized in that: One end of the conduit (502) away from the second fixed pipe (402) is mounted on the flow meter (7).
6. The nitric oxide connection device for treating pulmonary hypertension according to claim 1, characterized in that: A vertical pipe (11) is installed on the top of the flow meter (7), and the NO2 monitor (8) is installed on the outside of the vertical pipe (11).
7. The nitric oxide connection device for treating pulmonary hypertension according to claim 1, characterized in that: The connecting tube (9) is installed on the outside of the NO2 monitor (8), and the breathing machine tube (10) is sleeved on the outside of the connecting tube (9).